Erik A. Eklund

2.6k total citations
70 papers, 1.7k citations indexed

About

Erik A. Eklund is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Erik A. Eklund has authored 70 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 20 papers in Physiology and 16 papers in Organic Chemistry. Recurrent topics in Erik A. Eklund's work include Glycosylation and Glycoproteins Research (28 papers), Carbohydrate Chemistry and Synthesis (16 papers) and Lysosomal Storage Disorders Research (8 papers). Erik A. Eklund is often cited by papers focused on Glycosylation and Glycoproteins Research (28 papers), Carbohydrate Chemistry and Synthesis (16 papers) and Lysosomal Storage Disorders Research (8 papers). Erik A. Eklund collaborates with scholars based in Sweden, United States and Netherlands. Erik A. Eklund's co-authors include Hudson H. Freeze, Bobby G. Ng, Marc C. Patterson, Liangwu Sun, Mats Jönsson, Mattias Belting, Anders Wittrup, Staffan Sandgren, Fang Cheng and Susann Busch and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and American Journal of Clinical Nutrition.

In The Last Decade

Erik A. Eklund

64 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik A. Eklund Sweden 21 1.0k 322 303 280 256 70 1.7k
Maria Blomqvist Sweden 22 701 0.7× 316 1.0× 285 0.9× 213 0.8× 79 0.3× 51 1.4k
James A. Mahoney United States 14 848 0.8× 745 2.3× 202 0.7× 135 0.5× 199 0.8× 22 1.8k
Marie‐Sylvie Gross France 22 1.1k 1.1× 226 0.7× 236 0.8× 113 0.4× 164 0.6× 43 1.9k
Annabel N. Smith United Kingdom 18 1.0k 1.0× 144 0.4× 130 0.4× 94 0.3× 49 0.2× 25 1.8k
Matthias Gautschi Switzerland 21 1.1k 1.1× 209 0.6× 289 1.0× 289 1.0× 83 0.3× 55 1.8k
Marja‐Leena Majuri Finland 26 699 0.7× 553 1.7× 234 0.8× 85 0.3× 104 0.4× 44 1.7k
Adriano Spreafico Italy 25 713 0.7× 132 0.4× 116 0.4× 43 0.2× 92 0.4× 50 1.6k
Martina Wilke Netherlands 22 651 0.6× 372 1.2× 128 0.4× 63 0.2× 40 0.2× 52 1.6k
Kazuhiro Sugihara Japan 20 749 0.7× 369 1.1× 59 0.2× 292 1.0× 56 0.2× 48 1.4k
Kin Lam Fok Hong Kong 22 605 0.6× 302 0.9× 54 0.2× 71 0.3× 33 0.1× 51 1.5k

Countries citing papers authored by Erik A. Eklund

Since Specialization
Citations

This map shows the geographic impact of Erik A. Eklund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik A. Eklund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik A. Eklund more than expected).

Fields of papers citing papers by Erik A. Eklund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik A. Eklund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik A. Eklund. The network helps show where Erik A. Eklund may publish in the future.

Co-authorship network of co-authors of Erik A. Eklund

This figure shows the co-authorship network connecting the top 25 collaborators of Erik A. Eklund. A scholar is included among the top collaborators of Erik A. Eklund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik A. Eklund. Erik A. Eklund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eklund, Erik A., et al.. (2025). The effect of elexacaftor–tezacaftor–ivacaftor on liver stiffness in children with cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 81(1). 74–81.
2.
Karlsson, Michael, Fredrik Sjövall, Eleonor Åsander Frostner, et al.. (2024). Correlation of mitochondrial respiration in platelets, peripheral blood mononuclear cells and muscle fibers. Heliyon. 10(5). e26745–e26745. 6 indexed citations
3.
Radenkovic, Silvia, et al.. (2024). Coagulation abnormalities and vascular complications are common in PGM1-CDG. Molecular Genetics and Metabolism. 142(4). 108530–108530. 2 indexed citations
4.
Eklund, Erik A., Bradley S. Miller, & Alexander A. Boucher. (2023). Thrombosis risk with estrogen use for puberty induction in congenital disorders of glycosylation. Molecular Genetics and Metabolism. 138(4). 107562–107562. 2 indexed citations
5.
Eklund, Erik A., et al.. (2023). Ophthalmic manifestations in children with tuberous sclerosis complex. Acta Ophthalmologica. 102(4). 421–427. 1 indexed citations
6.
Lundgren, Johan, et al.. (2023). Childhood tuberous sclerosis complex in southern Sweden: a paradigm shift in diagnosis and treatment. BMC Pediatrics. 23(1). 329–329. 9 indexed citations
7.
8.
Ljungblad, Ulf, et al.. (2022). Nitrous oxide in labour predicted newborn screening total homocysteine and is a potential risk factor for infant vitamin B12 deficiency. Acta Paediatrica. 111(12). 2315–2321. 9 indexed citations
9.
10.
Eklund, Erik A., et al.. (2021). Abnormal glucose tolerance and lung function in children with cystic fibrosis. Comparing oral glucose tolerance test and continuous glucose monitoring. Journal of Cystic Fibrosis. 20(5). 779–784. 25 indexed citations
11.
Kotarsky, Heike, Rejane Augusta de Oliveira Figueiredo, Matthias Mörgelin, et al.. (2019). Fasting reveals largely intact systemic lipid mobilization mechanisms in respiratory chain complex III deficient mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(1). 165573–165573. 6 indexed citations
12.
Ng, Bobby G., Hunter R. Underhill, Lars Palm, et al.. (2018). DPAGT1 Deficiency with Encephalopathy (DPAGT1-CDG): Clinical and Genetic Description of 11 New Patients. JIMD Reports. 44. 85–92. 15 indexed citations
13.
Tegelberg, Saara, Jukka Kallijärvi, Janne Purhonen, et al.. (2017). Respiratory chain complex III deficiency due to mutated BCS1L: a novel phenotype with encephalomyopathy, partially phenocopied in a Bcs1l mutant mouse model. Orphanet Journal of Rare Diseases. 12(1). 73–73. 18 indexed citations
14.
Mori, Michiko, Michael Dictor, Nicholas Brodszki, et al.. (2016). Pulmonary and pleural lymphatic endothelial cells from pediatric, but not adult, patients with Gorham-Stout disease and generalized lymphatic anomaly, show a high proliferation rate. Orphanet Journal of Rare Diseases. 11(1). 67–67. 7 indexed citations
15.
Kranz, Christian, Liangwu Sun, Erik A. Eklund, et al.. (2007). CDG‐Id in two siblings with partially different phenotypes. American Journal of Medical Genetics Part A. 143A(13). 1414–1420. 31 indexed citations
16.
Sun, Liangwu, et al.. (2005). Congenital Disorder of Glycosylation Id Presenting with Hyperinsulinemic Hypoglycemia and Islet Cell Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 90(7). 4371–4375. 74 indexed citations
17.
Eklund, Erik A. & Hudson H. Freeze. (2005). Essentials of Glycosylation. Seminars in Pediatric Neurology. 12(3). 134–143. 12 indexed citations
18.
Miura, Yoshiaki, S K Tay, Marion Aw, Erik A. Eklund, & Hudson H. Freeze. (2005). Clinical and Biochemical Characterization of a Patient with Congenital Disorder of Glycosylation (CDG) IIx. The Journal of Pediatrics. 147(6). 851–853. 16 indexed citations
19.
Tiedemann, Kerstin, Erik A. Eklund, Lizbet Todorova, et al.. (2005). Regulation of the chondroitin/dermatan fine structure by transforming growth factor-β1 through effects on polymer-modifying enzymes. Glycobiology. 15(12). 1277–1285. 42 indexed citations
20.
Bode, Lars, Erik A. Eklund, Simon Murch, & Hudson H. Freeze. (2004). Heparan sulfate depletion amplifies TNF-α-induced protein leakage in an in vitro model of protein-losing enteropathy. American Journal of Physiology-Gastrointestinal and Liver Physiology. 288(5). G1015–G1023. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Blomqvist Breakdown of academic impact, for papers by James A. Mahoney Breakdown of academic impact, for papers by Marie‐Sylvie Gross Breakdown of academic impact, for papers by Annabel N. Smith Breakdown of academic impact, for papers by Matthias Gautschi Breakdown of academic impact, for papers by Marja‐Leena Majuri Breakdown of academic impact, for papers by Adriano Spreafico Breakdown of academic impact, for papers by Martina Wilke Breakdown of academic impact, for papers by Kazuhiro Sugihara Breakdown of academic impact, for papers by Kin Lam Fok
Rankless by CCL
2026